Photo by Innerbody Research
If you're like us, the terms "microbiome" and "gut–brain axis" probably make frequent appearances in your online search results, maybe even your everyday speech. We're referring, of course, to the billions of helpful bacteria that live in and on your body and the far-reaching effects they can have in multiple areas of your health.
Seed is a specialist in the space that offers three products aimed at correcting, improving, and optimizing your microbiome. It certainly has plenty of market competition, so we understand if you feel overwhelmed by choosing between it and its competitors. We've written this review to help you make the decision and determine where Seed stands in the probiotics landscape.
Seed’s three synbiotic products, each aimed at a different demographic, contain clinically relevant numbers of live, viable bacterial strains, many of which have scientific research to support their purported health benefits. The company’s practices — in terms of production, safety, and sustainability — are admirable, too, and the shipping costs are either nil or very low. However, the formulations may also contain strains that have little evidence behind them, and the cost of a Seed subscription is higher than most comparable products, so certain consumers may prefer to go with a more cost-effective alternative whose ingredients have greater scientific backing.
Seed probiotics can be purchased directly from the company, through its Amazon storefront, or at certain brick-and-mortar chains (e.g., Target). A direct online purchase is probably the best option for most people. Although it requires a subscription, it also offers access to a wider product range and lower prices, and you can approximate a one-time purchase by canceling your subscription before the next billing cycle. The Amazon or in-store route is more expensive and would be preferable only to those who don't want to bother with the whole cancellation step.
Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions involving staying healthy and living healthier lifestyles.
Our Seed probiotics review involved 100 relevant sources and more than 50 research hours. We closely read dozens of scientific papers relevant to the ingredients found in Seed's formulations and assessed the company's processes to evaluate product efficacy, safety, and convenience. Research aside, we also took on the customer role, as practical knowledge plays an integral part in every review we write. We not only interacted with Seed's customer support but also purchased Seed products, tried them to the extent we could, and recorded our observations. Our efforts have allowed us to present a well-rounded perspective on the company's offerings and the Seed user experience.
Additionally, like all health-related content on this website, this review was thoroughly vetted by one or more members of our Medical Review Board for accuracy.
Our evaluations of Seed probiotics centered on the five criteria we believed were most likely to influence readers’ purchasing decisions: efficacy, safety, cost, convenience, and sustainability. Efficacy, safety, and cost are typically our principal evaluative factors because we want consumers to gravitate to products that work well without endangering them, and we want our recommendations to be accessible to the widest possible audience. As for convenience, we think a straightforward route of administration correlates with easier daily use, which is bound to influence a person’s overall impression of a product.
Now, sustainability isn’t something we always rate, but it’s such a key part of Seed’s brand identity that we’d be remiss to ignore it.
Here’s how Seed measured up in each category:
A first glance at the company’s formulations tells us Seed does a couple of things right: The probiotics are specified down to the strain, and they’re quantified by the number of viable bacterial cells. Such labeling measures are important because probiotic benefits are often strain-specific,1 and viable cell counts give a sense of a product’s potential to impart its purported benefits.
A closer examination of the formulations reveals some positives and some negatives. The negatives relate largely to strains with little scientific backing, including a large proportion of the bacteria in DS-01 and all three strains in VS-01. What supportive studies we could find were Seed-funded. Self-funding isn’t necessarily a red flag, but it gives some reason to be skeptical of the findings. Also, about those viable cell counts — Seed lists them in groups categorized by intended outcome (e.g., gut health, respiratory health, skin health). The International Scientific Association for Probiotics and Prebiotics (ISAPP) states that 1 billion CFU is the minimum effective quantity per serving,2 which each of Seed's outcome groups exceeds considerably, but the grouped numbering means we can’t tell by the label whether the best-supported strains are present in high enough numbers to truly be effective.
Despite all that, we think the positives are sufficient to earn Seed its 7.0 efficacy rating. For the strains we could corroborate with research (e.g., Bifidobacterium longum BB53 and Bifidobacterium breve BR3), the clinical evidence for their benefits is strong. Also, Seed’s encapsulation methods, including a proprietary dual-capsule system for DS-01, seem quite valid for preserving probiotic viability within the harsh environment of the gastrointestinal (GI) tract, even though the relevant research is self-funded. As to those self-funded studies, we can acknowledge that the study methods were sound, and we don’t dismiss the possibility that future research may validate their findings.
Our rating accounts for our subjective testing as well. While our testers hadn’t experienced much in the way of GI complaints beforehand, they did experience alleviated bloating after trying Seed.
We can’t defer to the U.S. Food & Drug Administration (FDA) to confirm safety here since dietary supplements such as probiotics are outside the FDA’s purview. Instead, we have to examine a company’s operational practices and ingredient bills to confirm safety.
On that front, Seed does a terrific job. Apart from the probiotics themselves, which the Office of Dietary Supplements describes as "unlikely to cause harm in healthy people,"1 all of the ingredients in Seed’s products are generally recognized as safe. Plus, the company conducts third-party testing at multiple production stages to ensure the products are:
The few safety dings relate to health risks for relatively small populations. For example, the PDS-08 Pediatric Daily Synbiotic contains inulin/fructooligosaccharides as a prebiotic, which isn’t suitable for people who can’t consume fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs).
Only by the barest margin does Seed avoid being designated as the most expensive synbiotic among our recommendations, and that really only applies to its two daily synbiotics. DS-01 and PDS-08 each cost $49.99 per month, making them a few dollars less than Ritual Synbiotic+ at its normal, undiscounted price. Seed’s cost rating would’ve been a few decimal points higher if the VS-01 Vaginal Synbiotic didn’t average out to a $41.66 monthly price, which is significantly higher by both unit cost and per-use cost than competitors Jarrow and VagiBiom.
What really saves Seed in this category is shipping. All domestic orders ship for free, regular international shipping costs a flat rate of just $10, and overseas customers can opt into free shipping by enrolling in Seed’s Sustainable Refills Program (more on that under the “Cost” criterion).
Our testers found DS-01 Daily Synbiotic quite easy to use. It’s a “standard”-size capsule measuring 2cm long and 0.5cm wide (seven-eighths of an inch and one-quarter inch, respectively). As long as you don’t have trouble swallowing pills, Seed’s marquee product should go down easily. The company recommends an acclimation period when you start out, but the system is clearly laid out in the accompanying booklet.
The VS-01 Vaginal Synbiotic is less convenient since it requires vaginal insertion, but discomfort should be minimal for those who are accustomed to using tampons. The applicator is, in fact, no wider than a regular-size tampon, and the probiotic tablet is the same width as DS-01. Of course, if you have a pelvic health condition that prevents intravaginal use (e.g., vaginismus),3 you’ll probably prefer an oral alternative like Jarrow.
We didn’t order the PDS-08 Pediatric Synbiotic, so we can’t speak firsthand about using it, but we appreciate that it’s a microencapsulated powder that children can sprinkle into whatever drink or food they want. A gummy form, like Smarty Pants, might appeal better to some users, but that comes down to personal preference.
Seed is one of the most environmentally conscious brands we’ve reviewed. Practically everything in the box is either reusable or easily biodegradable. DS-01, for example, comes in a glass jar and includes a glass travel vial. You keep the jar and vial, and when you get a refill, which arrives in a compostable pouch, you dump the contents into them. Even the protective “foam” in which the products come nestled is made of materials that can go in either the recycling bin or the compost heap. The only materials we could see that weren’t recyclable or compostable were the VS-01 applicators and their wrapping.
Photo by Innerbody Research
Not only that, but Seed encourages overseas customers to reduce their carbon footprint through its Sustainable Refills Program. Participants agree to pay for three months of product up front in exchange for free international shipping. It may be a small contribution to reducing global emissions, but it’s also an incentive we respect and one we’ve scarcely seen offered by other supplement brands.
Seed is a subscription-only supplement service, like Ritual, but it differentiates itself in that it specializes in broad-spectrum synbiotics. The colloquial understanding of "synbiotic" is a product that combines probiotics (beneficial microorganisms) and prebiotics (food for probiotics).4 5 In a 2020 statement, the ISAPP qualified the definition to recognize two subcategories:6
Seed's entire product line fits the "complementary" designation; the bacterial compositions are thoughtfully assembled to achieve specific outcomes, but the prebiotic component is largely one-type-feeds-all. Being a complementary synbiotic isn't a bad thing, though. The authors of a 2022 review note that almost all synbiotics used in clinical trials are complementary, and many have proven to provide "important health benefits on the tested population."7
As a company, Seed further distinguishes itself from the competition in several key aspects. The following sections describe what we think are three key points of differentiation.
Seed separates itself from competitors like Ritual and Peak Performance not only in that it specializes in synbiotics but also that it offers multiple synbiotic formulations, two of which serve specific demographics. At the time of this writing, Seed's product line includes three distinctive synbiotic formulations. We'll cover the science behind their respective formulations in the section titled “How do Seed probiotics work?” For now, though, let's discuss what each product entails and the benefits it's designed to achieve.
DS-01 Daily Synbiotic is Seed's marquee product. Intended for users aged 18 and older, it's a capsule that contains 24 bacterial strains totaling 53.6 billion active fluorescent units (AFU). Sixteen of the strains (37 billion AFU) are aimed at improving digestive health, gut immunity, and gut barrier integrity; four (3.3. billion AFU) are for dermatological health; two (5.25 billion AFU) promote cardiovascular health; and another two (8.05 billion AFU) go toward "micronutrient synthesis." Feeding the bacteria are 400mg of Microbiota-Accessible Polyphenolic Precursors (MAPP) composed of whole-fruit Indian pomegranate.
A daily serving of DS-01 is two capsules. Seed recommends an acclimation period when you begin, which entails taking one tablet on each of the first three days before moving on to the full serving size thereafter.
The DS-01 box includes a glass travel vial that’s essentially a taller, slimmer, and more portable version of the regular jar. We think that’s a handy addition for when you need to take your Seed dose on the go. It’s pretty tough, too. It withstood multiple four-foot drop tests on a kitchen floor without so much as a scratch, so it should easily survive jostling in a backpack, shoulder bag, or suitcase. Keep a firm grip outside, though; the pavement drop test we performed was the final one we could do.
PDS-08 is a scaled-down version of DS-01, formulated for young people aged 3-17. Here, we have nine bacterial strains totaling 24.5 billion AFU. Four strains (17 billion AFU) target GI health; two (2 billion AFU), respiratory health; and three (1 billion AFU), dermatological health. The 6g prebiotic blend consists of inulin/fructooligosaccharides instead of polyphenols. With the younger target audience in mind, Seed has manufactured the pediatric formulation as a powder that mixes into foods and beverages. Microencapsulation protects the powder’s probiotics through the GI tract.
Delivered intravaginally, like competitor VagiBiom, VS-01 Vaginal Synbiotic is aimed at adult women aged 18-55. Its active ingredients are three proprietary strains of Lactobacillus crispatus, a species known to inhibit bacterial vaginosis (BV),8 while maltose and calcium lactate play the prebiotic-postbiotic support roles. BV, a condition resulting from bacterial imbalance in the vagina, can cause unpleasant symptoms such as discharge, odor, itching, and a burning sensation during urination.9 It can be prevented by maintaining a healthy vaginal microbiome, which is what VS-01 aims to establish.
Your VS-01 subscription begins with a two-month starter kit. Inside, your suppositories are separated into a Reset phase and a Sustain phase. You begin the Reset phrase immediately after your period ends; afterward, you’re to use it again on days four, seven, fourteen, 21, and 28 to establish a healthy vaginal microbiome. Then you move on to the two-tablet Sustain phase, in which you again insert the first tablet after your period ends and the second one on day 14. Subsequent months follow the two-tablet Sustain routine. The kit includes a booklet that lays out the schedule and in which you can track your use.
You may have noticed by now that Seed measures viable bacterial quantity not by colony-forming units (CFU) but by AFU. So, what's the difference?
CFU refers to a single organism that can produce a colony, or a bacterial population. Think of it as the ancestor from which a complex family tree originally branches, only that each successive generation arises in a matter of minutes rather than decades. Probiotic supplements — including Seed's competitors Ritual and Ombre — typically measure their contents by CFU, with higher numbers corresponding to a larger quantity of helpful microorganisms that can multiply.
Probiotic consumers often equate high CFU with superior probiotic efficacy, but probiotics don't exactly work that way. Some supplements contain filler species that aren't necessarily helpful to the microbiome they populate, but they help inflate the marketable bacteria count. Also, providers count CFU at the time of manufacture, and not all of the bacteria that were viable at the time will remain viable by the time you consume the product.
AFU is another way to enumerate the viable bacteria in a probiotic supplement, though in a potentially more accurate manner. It relies on a technology called flow cytometry, which uses lasers to illuminate dye-marked single cells and detectors to read the light signals.10 A 2023 paper published in Foods describes AFU as a "more precise method ... for counting viable microorganisms" because it can identify microorganisms that survive production but aren't viable.11
With all that considered, we want to note that bacterial cell counts do matter in a broad sense. The more microorganisms that were viable at production, the more likely that you’ll have sufficient quantities to ingest. Also, in a 2014 consensus statement, the ISAPP considers 1 billion CFU to be the minimum effective quantity of microorganisms per serving.2
The key takeaway is that AFU, as used by Seed, can give you a more spot-on sense of a probiotic's ability to proliferate its bacterial cells and, therefore, establish a healthy microbiome.
Most environmental pollution is industrial,12 so we think it's important to highlight companies that demonstrate a strong commitment to sustainability. Seed isn't the only environmental champion in the supplements space, but it takes (and promotes) much stronger measures compared to the competition.
For example, most of the company's packaging is biodegradable. All products come in outer boxes made with algae paper that's FSC certified, which designates a product sourced from "responsibly managed forests that provide environmental, social and economic benefits.”13 With the DS-01 Daily Synbiotic, the contents are protected by an inner "foam" that derives from starch and natural fibers that are suitable for the recycling bin or the compost pile (the DS-01 refill pouches are safe for the compost, too, while the PDS-08 refill sachets consist of 40% post-consumer recycled material). Even the peel-away sticker on the jar is recyclable.
Speaking of the jar, it's reusable. The DS-01 Daily Synbiotic jar is made of thick frosted glass with a 100% post-consumer recycled plastic lid, and the PDS-08 Pediatric Daily Synbiotic is made of aluminum. You're meant to keep the original bottle and dump your refills into it.
The only item that doesn't come in a fully biodegradable mechanism is the VS-01 Vaginal Synbiotic, whose applicator can't be recycled.
Photo by Innerbody Research
For the sake of comparison, consider Ritual's product packaging, which consists of polyurethane. Although it's recyclable, it isn't biodegradable. Indeed, it can take around 450 years to decompose, whereas biodegradable materials take no more than six months.14
Probiotic supplements, in general, work similarly. The idea is to get the beneficial bacteria to the environment you want to target (e.g., the gut), where they compete with pathogenic bacteria, produce beneficial substances, or help bolster your body's immune response.15
A supplement's efficacy relies largely on its formulation and delivery. Ideally, the formulation details its contents down to the strain level because probiotic benefits are often strain-specific,1 and the delivery mechanism should ensure the contents survive their transit toward their target destination. In the following sections, we discuss these variables as they specifically relate to Seed's synbiotic products.
Photo by Innerbody Research
Seed's DS-01 Daily Synbiotic contains 24 distinct strains across four outcome categories:
In addition, it contains a powerful prebiotic in Indian pomegranate, whose polyphenols induce a "synergistic effect" with probiotics.16 The 400mg prebiotic dose appears to be on the low side, however, as successful studies on human inflammatory bowel disorders have used quantities of 6g per day,17 while mouse studies have used doses equivalent to around 1,100mg in a 70kg (155lb) human.18
The vastness of the DS-01 formulation certainly differentiates Seed's marquee product from direct competitors like Ritual and Peak Performance, but number and variety don't mean anything unless the specific strains are proven to deliver the product's purported benefits.
Photo by Innerbody Research
Below, we discuss the most promising contents in the DS-01 formulation to determine whether it truly can deliver on its health potential.
A 2023 review in Gut Microbes describes Bifidobacterium longum as the "most abundant species" in the neonatal (newborn) gut, but one whose "relative abundance declines with age." The same review states it can impart "far-reaching effects" in not only the lungs and skin but also the gut.19 Concerning gut health, the BB536 strain, specifically, has helped to resolve abdominal pain in children with irritable bowel syndrome (IBS) and to improve the gut microbiota composition in infants.20 21 There have been similar findings in adult studies.22
In a 2010 study, participants who received Bifidobacterium breve BR3 in a probiotic blend reported improvements in weekly bowel movement frequency, fecal consistency, and ease of fecal evacuation.23 Furthermore, a 2012 in vitro study found that it may have the potential to inhibit the growth of Escherichia coli (E. coli),24 a potentially life-threatening foodborne pathogen.25
Lactiplantibacillus plantarum LP1 was also included in the probiotic blend used in the above-referenced 2010 study on bowel function,23 as well as the in vitro study on E. coli inhibition.24 Elsewhere, it has demonstrated the ability to antagonize pathogenic overgrowth in the guts of subjects with reduced gastric acid secretion and to inhibit the inflammatory cytokines and reactive oxygen species associated with Parkinson's disease (also in vitro).26 27
Concerning Bifidobacterium infantis M63, we found one study that we considered relevant to DS-01's health effects on adult populations: a 2018 trial on M63's mental health impact in adults with IBS following a "major flood disaster" in Malaysia. M63 supplementation appeared to restore participants' gut microbial balance and improve their mental health markers. The researchers acknowledge their study was limited by a small sample size.29
The connection between IBS and mental health may seem tenuous on the surface, but the gut and brain are functionally linked,30 and research shows that up to one-third of people with IBS experience psychological symptoms like anxiety and depression.31
Lacticaseibacillus rhamnosus GG is a common strain among probiotic supplements. A 2014 review notes that its ability to treat GI symptoms is "well documented," as is its potential to stimulate immune responses and prevent "certain allergic symptoms."32
Bifidobacterium lactis CECT8145, part of DS-01's Dermatological Health Probiotic Blend, has shown the potential to improve symptoms in children with atopic dermatitis, per one post hoc analysis of a 2021 clinical trial.33 It may also help to improve obesity biomarkers thanks to the fat-reducing properties of its lipoteichoic acid.34 CECT8145’s effects on obesity may have promising implications for skin health owing to the gut–skin axis.35
Bifidobacterium longum CECT7347 was also part of the 2021 clinical trial on atopic dermatitis,33 while a separate study from 2021 highlights its ability to reduce "inflammatory response and gut-barrier disruption."36 Interestingly, the authors of the latter study also point to CECT7347's capacity to improve skin conditions like atopic dermatitis and psoriasis, which are linked to intestinal barrier function.37 38
Lacticaseibacillus casei CECT9104 is yet another strain evaluated in the 2021 atopic dermatitis trial.33 For further proof of its utility in treating skin ailments, we can look to the same 2018 trial that studied CECT7347's effects on atopic dermatitis scores and reduced reliance on topical steroids, referenced above.37
Bifidobacterium lactis MB2409, which is one of the strains in DS-01's Cardiovascular Health Probiotic Blend, was among the subjects in a 2013 study that supported its ability to reduce plasma cholesterol and promote healthy aging.39
These strains, which make up DS-01's Macrobiotic Synthesis Blend, are aimed at helping the body produce and synthesize vitamins B9 and B12 — essential compounds that cooperate to produce red blood cells and support iron function.40 A 2021 review in the International Journal of Molecular Sciences confirms that BA5 does indeed synthesize B9 and LRE2 does produce B12.41
The information you've just read covers 12 of the bacterial strains in the DS-01 synbiotic. Does that mean half of its active ingredients are ineffective? Not exactly. But it does mean there isn't enough reliable research tying the specific strains to their purported effects.
In some instances, the studies we've found don't relate at all to the health outcomes that Seed claims for a particular strain. Such is the case with Lactobacillus crispatus SD-LCR01-IT; while it's a component of Seed's Digestive Health/Gut Immunity/Gut Barrier Integrity blend, we couldn't find any peer-reviewed research to support its use to that end. We can say that Lactobacillus crispatus as a species is commonly found in healthy human guts,42 but nothing definitive about the strain in question.
For others, the most relevant research we could find was self-funded. One is a 2023 in vitro study financed by Seed on the restoration and enhancement of gut function by the following strains in gut models disrupted by antibiotics or alcohol:43
The other is a study examining the mechanisms of action behind the cholesterol-lowering activity of Lactiplantibacillus plantarum LPLDL (part of Seed's Cardiovascular Health Probiotic Blend), whose funding appears to come from the company that produced the LPLDL strain, OptiBiotix.44
We've said in other reviews that self-funded research isn't necessarily bad, but it does leave the possibility that bias informed the findings. We can appreciate, though, that the methods in both studies seem sound for in vitro experiments.
For comparison's sake, direct competitor Ritual Synbiotic+ has a much simpler formulation with well-researched bacterial strains, Bifidobacterium lactis BB12 and Lactobacillus rhamnosus GG.45 46
Another direct competitor, Peak Performance Synbiotic Capsules, also has a simple formulation consisting of three well-studied species — Bacillus coagulans,47 subtilis,48 and clausii49 — but it doesn't specify strains the way Seed and Ritual do.
Against these competitors, Seed DS-01 seems to offer a broader range of health applications, but its comparably low proportion of well-researched strains to novel ones leaves something to be desired.
Let's imagine for a moment that all of the microorganisms in your supplement survived the transit from the production line to your body. Even then, with oral probiotics, they have to contend with another transit route to reach their target destination: your GI tract. Here, we explain how Seed overcomes the hazards of GI transit.
The stomach is the first major obstacle. To quote a 2021 review, acidic gastric fluid is "extremely lethal to most bacteria," including those contained in a probiotic capsule. Not only that, but "ionic strength, enzyme activity (pepsin), and mechanical churning" can also affect probiotic viability. Species such as Bifidobacterium longum and breve may become "undetectable" within an hour spent in the stomach. That means goodbye to some of those gut and respiratory health benefits.50
Probiotic bacteria that survive the stomach must then face the bile and digestive enzymes in the small intestines. It's here, for example, that Lactobacillus salivarius, a key species for respiratory health benefits, sheds some of its viability.50
Probiotic manufacturers overcome GI obstacles through different encapsulation methods. Seed has developed its own method called ViaCap, which entails protecting the inner probiotic capsule with an outer capsule, both made of hydroxypropyl methylcellulose and intended to preserve the probiotic contents as they travel from the stomach to the colon.
ViaCap is a novel solution, and research so far is limited to a self-funded study from 2021 that used a simulated gut model. The study revealed that ViaCap successfully protected the probiotic contents from the harsh GI environment and delivered bacterial numbers that were "highly comparable" to those within the capsule before experimentation.41 In other words, most of the viable contents in Seed's capsule survived the trip to the colon, where probiotics have their biggest impact.51 For perspective, consider that strain survival rates in the GI environment are normally just 20-40%, per a 2001 analysis.52
Once more, we have to address the limitations of self-funded research, but we acknowledge what this particular study did right. That is, the gut model used was the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). The use of SHIME is significant because it's one of the few models that simulate the whole GI tract,53 so it accurately represents how a supplement reacts to the GI environment. We can be skeptical about the study's financial sourcing but also trust the findings to be fair.
Seed's PDS-08 Pediatric Daily Synbiotic is a powder that can be sprinkled into beverages or foods so that your child doesn’t feel as though they’re taking medicine. The powder is “mildly sweet” (per Seed) as well as microencapsulated, a method shown to protect probiotic contents as they travel through the GI tract.54
The PDS-08 formulation has five bacterial strains in common with DS-01:
That leaves two unique strains for gut health and two more for respiratory health. In order of correspondence with their outcome categories, they are:
NCFM is often studied in conjunction with Bifidobacterium lactis Bi07 (discussed below). A 2011 double-blind study found the combination to be effective in improving bloating symptoms related to functional bowel disorders.55
Research indicates that Bifidobacterium lactis Bi07 can provide several gut health benefits. A 2022 study supports its ability to alleviate lactose maldigestion;56 a 2014 study suggests it may improve immune function related to gut microbiota;57 and the above-referenced 2011 study showed it works alongside NCFM to relieve bloating in people with functional bowel disorders.55
While much of the research on B632 concerns its influence on GI health and infant colic,58 studies do suggest it can provide respiratory benefits as well. For example, in a 2022 trial, supplementation with B632 on pediatric subjects with asthma successfully reduced asthma symptoms in frequency and severity.59
A 2015 study on the immunomodulatory effects of Ligilactobacillus salivarius LS01 found that it could help inhibit the secretion of pro-inflammatory cytokines associated with "asthma severity, lung function, and airways hyper-responsiveness in asthmatic patients."60
We're pleased that all of PDS-08's bacterial strains have research to support their intended outcomes. Also, because direct competitors Ritual and Peak Performance don't offer formulations specifically for children, we can say Seed truly stands apart in the pediatric synbiotic niche.
You should know that PDS-08 uses a different prebiotic than DS-01. Rather than pomegranate, its prebiotic blend consists of inulin/fructooligosaccharides from chicory root. Research supports their prebiotic function.61 62 Doses larger than 5g see greater increases in beneficial microorganisms such as Bifidobacterium, so the 6g in PDS-08’s is clinically relevant.61 However, although Inulin/fructooligosaccharides are Generally Recognized as Safe by the FDA, they aren't suitable for people sensitive to FODMAP ingredients.63 64 If you need to follow a low-FODMAP diet, using Seed's PDS-08 synbiotic may cause bloating, cramping, constipation, diarrhea, gas, and other GI symptoms.65
The competitors we’ve mentioned so far, Ritual and Peak Performance, don’t produce synbiotics specifically formulated for young people, so we have to look elsewhere to see where PDS-08 stands in its submarket. Two directly comparable products we’ve found are:
You can think of Smarty Pants as a parallel to Ritual Synbiotic+ since it has a simple, two-piece probiotic formulation with well-researched strains: Bacillus subtilis DE111 and Bacillus coagulans MTCC5856.66 67
Garden of Life, on the other hand, is similar to Peak Performance Synbiotic Capsules in that it doesn’t specify its probiotic strains, but its species — Lactobacillus gasseri,68 Lactobacillus plantarum,69 Bifidobacterium lactis,70 Lactobacillus casei,71 and Lactobacillus acidophilus72 — have demonstrated benefits in areas like immune health, respiratory health, GI function, and many others that we’ll cover in a later section, “Alternatives to Seed probiotics.”
Photo by Innerbody Research
The VS-01 Vaginal Synbiotic gives us the simplest formulation of the Seed lineup.
Maltose and calcium citrate make up the proprietary prebiotic-postbiotic complex. Seed doesn’t reveal the quantities of either ingredient, so we can’t tell you whether the doses are clinically relevant. What we do know is that maltose has demonstrated the ability to facilitate Lactobacillus and transition the vaginal microbiota away from BV-related bacteria in rhesus monkeys,73 while calcium citrate has shown potential in rat studies to influence gut microbiota and inflammation.74
The probiotic blend contains just three strains of Lactobacillus crispatus, an important species for establishing an optimal vaginal environment because it can inhibit other bacteria and prevent BV.8 The three strains are:
All three come from a proprietary bank, and the relevant research comes from one Jacques Ravel, who co-chairs Seed’s scientific advisory board. The research in question is a randomized, placebo-controlled clinical trial from 2024 and is a preprint (new medical research that has yet to be peer-reviewed). The participants were all within Seed's target age range (18-54 years old). The researchers tested primarily for safety and secondarily for the abundance of Lactobacillus crispatus in the vaginal environment.75
The trial took place in two parts:75
All very promising, though we need to refocus on the fact that the trial is Seed-affiliated and not yet peer-reviewed or published. To reiterate, company affiliation isn't necessarily bad; we must be wary of potential bias, but this particular study's methods appear valid. The trial's preprint status isn't an automatic ding against it, either.76 The findings weren't submitted until late May 2024, and the peer-review process takes up to 14 weeks without delays.77 The thing is, delays are common in the post-COVID sciences space. At the time of this writing, we can allow that the trial may eventually find placement in a peer-reviewed journal, thereby validating its findings. If not, count on us to update our review to account for it.
Photo by Innerbody Research
Now, some vaginal probiotics, like Jarrow Fem-Dophilus, are oral supplements, not intravaginal ones, and there’s conflicting research about local versus oral administration of vaginal probiotics. A series of 14 randomized, controlled trials in 2022 showed the oral route to be more effective at treating BV, though we should note the researchers used specific probiotic strains not found in Seed and in conjunction with antibiotics.78 An earlier study suggests roughly equal efficacy between the two routes of administration but acknowledges the possibility of superior efficacy, not to mention convenience, with oral probiotics.79 Yet an even earlier study stated that local administration led to faster effects compared to oral delivery, with healthful effects presenting in 2-3 days versus seven days.80
We can safely make two conclusions based on the evidence we have. The first is that more research is needed to determine whether one route is better than the other. And second, as both routes demonstrate efficacy at this time, the choice is yours to make.
With that said, Seed’s VS-01 delivery system is promising in that it circumvents an obstacle that oral probiotics face: preserving viability as they travel through the GI tract (discussed in an earlier section, "ViaCap: Seed's DS-01 oral delivery system").
On the broadest level, Seed's three synbiotic products may be helpful to people in their respective target populations who want to take active approaches to their microbiotic health — DS-01 for adults, VS-01 for women, and PDS-08 for young people aged 3-17.
More specifically, though, those who have or are at risk for dysbiosis (microbiome imbalance) stand to realize the greatest benefits from Seed's supplements. For those of you who aren't sure about the current state of your gut or vaginal microbiome, there are signs you can watch for and monitor. With gut dysbiosis, the symptoms are those associated with functional GI disorders — abdominal discomfort, bowel changes, bloating, nausea, vomiting, and a feeling of fullness — while vaginal dysbiosis is characterized by discharge, itching, and odor.81 82
Diet, lifestyle factors, and medications can influence your risk for either condition. Gut dysbiosis is the likeliest to arise in people who don't get enough fiber or exercise, and vaginal dysbiosis is linked to vaginal douching, poor nutrition, and having multiple sexual partners. Smoking, stress, and antibiotic use are additional risk factors for both, and genetics may play a role as well.83 84
If you've experienced any of the above symptoms or your circumstances match those we've mentioned, you could be an ideal candidate for a Seed synbiotic. Of course, before you make your order, you should speak with a doctor to confirm your suitability.
However, certain individuals, even those who might otherwise be ideal candidates, would be better off avoiding Seed and other probiotics owing to safety concerns. According to Harvard Health, people with weakened immune systems should steer clear.85That may include:
The concern here relates to compromised immune systems. Probiotics come with a small but serious risk of introducing a microorganism that can cause an infection. The U.S. National Center for Complementary and Integrative Health notes some cases of fatal infections and recommends weighing the risks to the benefits before embarking on a probiotic regimen.15 Choosing a supplement with third-party-verified ingredients, like Seed, is one safeguard against possible infection but isn't a guarantee against it. Again, you should consult your doctor to ensure safe use.
An additional exclusion criterion applies to Seed’s VS-01 Vaginal Synbiotic. Because it relies on the user’s natural vaginal lubrication to dissolve the supplement, it may be less effective or ineffective in those with vaginal dryness.
Broadly speaking, yes, Seed probiotics are safe for their intended users. The ODS states that common probiotic species are "unlikely to cause harm in healthy people,"1 and all of Seed's species, if not its strains, are common.
In addition, Seed adheres to rigorous third-party testing procedures at every stage of the manufacturing process to test for potency, survivability, contaminants, allergens, and thermostability, thereby ensuring its products are suitable for the broadest possible range of users. DS-01 and VS-01 are both tested for 14 classes of allergens, PDS-08 is tested for 20, and all three are suitable for vegans. What's more, DS-01 and PDS-08 are tested for heavy metals and compliant with the safe limits as defined by California's Proposition 65.86
However, the ODS warns that probiotics in general present a higher risk for harm in some populations on account of underdeveloped or reduced immune defenses, namely:1
Remember, too, that DS-01 and PDS-08, respectively, contain pomegranate and inulin/fructooligosaccharides as prebiotics. Therefore, they aren't suitable for people who are allergic or sensitive to such ingredients.
Even in low-risk populations, probiotics can cause unpleasant side effects. Most are minor GI symptoms (e.g., abdominal pain, bloating, gas, and stool changes). Others are more serious but rare (e.g., fatigue, headache, stress, depression, joint pain/stiffness).87
As with any supplement, we recommend you speak with a medical professional before adding Seed or another probiotic to your regimen.
Seed's synbiotics come at different price points. The following chart breaks down the per-unit and per-use costs of each product when purchased directly from the Seed website:
Supply | Per-unit $ | Approx. per-use $ | |
---|---|---|---|
DS-01 + refills | 30 days | $49.99 | $1.67 |
PDS-08 + refills | 30 days | $49.99 | $1.67 |
VS-01 Starter Kit | 2 months | $99 | $12.38 |
VS-01 refills | 1 month | $39.99 | $20 |
The DS-01 Daily Synbiotic gives you the option to bundle your supplement in three- and six-month supplies, discounting the per-unit price by 10% ($134.97 per shipment) and 15% ($254.95), respectively. All domestic subscriptions ship for free, international orders cost a surprisingly low $10 flat rate, and overseas customers can earn free shipping by enrolling in Seed's Sustainable Refills Program. The program entails quarterly billing and shipments of three-month supplies, with the $40 yearly savings being a reward for helping to reduce the carbon emissions associated with transit abroad.
For the most part, Seed's pricing structure falls in between its two most direct competitors in the synbiotics space, Ritual and Peak Performance. Ritual is the more expensive option overall; your first order costs $43.20 with a 20% Welcome Offer discount but then increases to $54 per month. Peak Performance is the budget alternative at $34.95 as a one-time purchase and $31.46 for a subscription; also, like Seed, the company offers opportunities for additional savings with three- and six-bottle bundles.
For our testing, we ordered the DS-01 Daily Synbiotic and the VS-01 Vaginal Synbiotic. The time from order to delivery was just four days, as advertised on the Seed website. It arrived in branded packaging, but the branding is distinguishable only from up close; the only thing that curious neighbors might have noticed are two hunter-green-colored parcels marked with tiny Helvetica type. Unless they, too, have researched Seed products, they'd have little reason to conclude they were looking at gut- and vaginal-health supplements.
Here's how our experiences went down with each product we ordered:
The DS-01 Daily Synbiotic lent itself easily to hands-on testing. We followed the acclimation schedule as directed: one capsule for each of the first three days, then full two-capsule servings thereafter. The booklet included in the box warns of "gastrointestinal discomfort, abdominal tightness, mild nausea, or changes to your stool" during the acclimation period. One tester attested to some abdominal tightness but nothing so remarkable as to seem unordinary. Your experience may differ, though, as everyone reacts to probiotics differently.
Testers had no difficulty swallowing the Seed capsules. Measuring 2cm long and 0.5cm wide (approximately seven-eighths of an inch and one-quarter inch, respectively), the capsules are what we consider "standard" size. Again, though, your experience may not align with ours. If you struggle to swallow pills, a product like Seed's Daily Synbiotic wouldn't suit you.
The matter of outcomes is harder to qualify, and it’s subjective, after all. Before testing, the one relevant complaint our testers could attest to was semi-frequent bloating (e.g., after a meal or after a period of not eating). On that front, they do say that two weeks' use of Seed DS-01 has provided relief. Once more, your own results may vary.
Our testing for the VS-01 Vaginal Synbiotic was explorational rather than practical. The initial Starter Kit comes with eight applicators and eight suppository tablets. The applicators are pretty much the same size as a regular tampon — a bit wider than a pencil and slimmer than a Sharpie — and each tablet measures 1.5cm (five-eighths of an inch) in length and 0.5cm (one-quarter inch) in width — approximately as large as an ordinary over-the-counter multivitamin.
The applicator has a plunger end and a loading end. To prepare it for use, you pull back the former and place the tablet in the latter; the tablet should stick out about a third of the way. From there, you insert the tablet intravaginally as you would a tampon and use it to place the tablet. Afterward, you toss the applicator into the waste bin.
Everyone has a unique microbiome, so we understand that Seed's synbiotics may not entirely suit your needs. Fortunately, the probiotics market is vast and growing and likely to include a product that satisfies your personal criteria.
We've mentioned Seed's direct competitors throughout this review. Here, we provide further information about them to help guide your purchasing decision and also discuss indirect competitors that may interest you.
The following brands may be appropriate alternatives to Seed's DS-01, PDS-08, and VS-01 supplements:
Ritual's Bifidobacterium lactis BB12 and Lactobacillus rhamnosus GG are known to enhance gut function, respiratory immune health, cardiovascular health, and even serious health conditions like nonalcoholic fatty liver disease.45 46 Its prebiotic comes in the form of PreforPro, which contains bacteriophages that target unwanted bacteria to eliminate competition for the beneficial strains.88 The formulation also includes a clinically relevant 300mg dose of CoreBiome tributyrin as a postbiotic (beneficial "waste" left by the pre- and probiotics), which can be helpful for GI disorders.89 90 Seed DS-01 does not include a postbiotic.
Ritual is a subscription-only service, and its Synbiotic+ costs $54 per month — around $4 more than Seed. The company offers a 20% Welcome Offer discount for the first purchase, bringing the first month's cost down to $43.20.
Peak Performance's three species of probiotic bacteria are Bacillus coagulans, Bacillus subtilis, and Bacillus clausii, all three of which have demonstrated healthful properties related to gut and immune function, among other things. The formulation contains CoreBiome tributyrin, like Ritual, but at a higher, 550mg dose. The prebiotic component is xylooligosaccharides, which has been found to successfully increase the numbers of helpful bacteria in the gut.91
The Peak Performance brand is considerably less expensive than either Seed or Ritual. A single bottle costs $34.95 as a one-time purchase and $31.46 as a subscription. Similar to Seed, Peak Performance also offers additional savings opportunities with multi-bottle bundles.
Smarty Pants is a chewable, Strawberry Creme–flavored synbiotic that, like Seed's PDS-08, is microencapsulated. Its Bacillus subtilis DE111 is a fairly fast-acting strain helpful for digestion, metabolism, and immune health,66 and its Bacillus coagulans MTCC5856 has been found to be effective as a component of adjunct therapy for diarrhea in children.67 Its prebiotic, beta-glucan, is a naturally occurring fermentable fiber in plants. According to a 2020 paper on the subject, beta-glucan's potential to promote good bacteria and inhibit the bad is similar to that of inulin,92 which itself is described as having an "outstanding effect" on intestinal microbiotic regulation in one 2023 review.93 However, while inulin isn’t suitable for people on low-FODMAP diets, fermentable fibers like beta-glucan appear less likely to trigger FODMAP symptoms.100 Of course, digestive disorders can affect individuals differently, so you should consult a medical professional to determine beta-glucan’s suitability to your child’s diet.
The Kids Prebiotic and Probiotic Immunity Formula is available only through Amazon but at a very low one-time price of $19.35 ($18.38 for a subscription).
Garden of Life Raw Probiotics Kids Cooler Powder is a powder formula that, like PDS-08, can be mixed into drinks and foods alike. The prebiotics include inulin and a wide assortment of fruits and vegetables (e.g., bananas, strawberries, spinach, brussels sprouts). As for the probiotics, while the label doesn't specify bacterial strains, it does list well-researched species — Lactobacillus gasseri for immune regulation, allergic symptoms, and lipid inhibition;68 Lactobacillus plantarum as an antimicrobial, antioxidant, anti-inflammatory, and immunomodulator;69 Bifidobacterium lactis for pathogenic protection, GI function, and respiratory health support;70 Lactobacillus casei for many applications, such as brain function and protection against allergies;71 and Lactobacillus acidophilus, helpful for lactose metabolism, immune response, and infection, to name a few.72
At $26.39 (reduced from $32.99), Garden of Life is another economical alternative to Seed's PDS-08. It doesn't appear to be microencapsulated, however, leaving the question of probiotic viability through the GI tract.
Jarrow Fem-Dophilus Vaginal & Urinary Tract is available in two varieties, 1 billion CFU and 5 billion CFU, both with the same two strains. The first is Lacticaseibacillus rhamnosus GR1, which a 2021 review describes as the "most studied vaginal probiotic strain for women’s health" and one whose ability to reduce the recurrence of BV and urinary-tract infections is "well documented."94 The other strain is Limosilactobacillus reuteri RC14. The RC14-GR1 combination has somewhat mixed results in clinical studies. A 2009 study found that coadministration of RC14 with GR1 could improve the cure rate for BV,95 but a 2021 study reported the two strains were "rarely detected" in the vaginal microbiota after oral intake. To be fair, the latter study did show the probiotic treatment had a cure rate pretty close to that of the prescription antibiotic metronidazole.96
The Jarrow product is available in 30- or 60-capsule packs at national stores such as Sprouts, Natural Grocers, and the Vitamin Shoppe, as well as the online retailer iHerb. The 1 billion CFU variety costs around $20-$34, while the 5 billion CFU version is around $32-$47. At any rate, the product's per-use cost ($0.67-$1.07) is significantly lower compared to VS-01.
VagiBiom is more directly similar to VS-01 because it's an intravaginal suppository with a prebiotic component, though the administration is manual, not via an applicator. Also, like VS-01's formulation, its probiotics — Lactobacillus acidophilus Bi14, Lactobacillus crispatus Bi16, Bacillus coagulans Bi34, and Lactobacillus gasseri Bi19 — aren't well studied, but we do have self-funded research to consult. The outcomes of the research were positive, showing that VagiBiom suppositories successfully reduced BV-related vaginal itching and improved Lactobacillus diversity in the vaginal microbiome.97 It bears repeating that self-funding gives reason to be skeptical, but the study's methods appear valid.
The VagiBiom suppository comes in packs of five, 15, and 30, with respectively corresponding costs of $17.95, $35.95, and $64.95. You can expect to use it 4-6 times per month depending on your needs. Your use frequency will determine the exact per-use cost.
Custom probiotics are unique formulations specifically tailored to your microbiome, whereas targeted probiotics are pre-formulated options recommended to you based on individual analysis. In either case, the provider formulates or recommends a probiotic product based on the results of an at-home microbiome test.
Our favorite such provider is Viome. For those looking to improve their gut microbiome, we'd recommend the company's Gut Intelligence Test along with the Precision Probiotics + Prebiotics plan. The test entails submitting a fecal sample and, a few weeks later, receiving the results of your analysis. If you subscribe to the Probiotics + Prebiotics plan, Viome will custom-create supplements designed specifically to address deficiencies in your gut microbiome. The test by itself costs $279 (or $169 with coupon INNERBODY), while the subscription comes with a free test and costs $79 per month (or $68 for the first six months with coupon INNERBODY15). Feel free to learn more about Viome in our dedicated review.
Viome doesn't currently offer a vaginal test, however. For that, Ombre may be the better option. For $119 ($89.99 with a subscription), the company will send you a collection kit that asks you to take and submit a vaginal swab. It will then analyze the swab and send you the results. Ombre doesn't make custom vaginal probiotics but will recommend relevant pre-formulated products that are likely to address any issues identified in your vaginal microbiome analysis. Head over to our Ombre review to find out more.
Sources
Innerbody uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
National Institutes of Health Office of Dietary Supplements. (2023). Probiotics: Fact sheet for health professionals. ODS.
Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506-514.
National Health Services. (2024). Vaginismus. NHS.
Cleveland Clinic. (2023). Probiotics. Cleveland Clinic.
Cleveland Clinic. (2022). What are prebiotics and what do they do?. Cleveland Clinic.
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., & Sanders, M. E. (2020). The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nature Reviews Gastroenterology & Hepatology, 17(11), 687-701.
Gomez Quintero, D. F., Kok, C. R., & Hutkins, R. (2022). The future of synbiotics: Rational formulation and design. Frontiers in Microbiology, 13.
Abdelmaksoud, A. A., Koparde, V. N., Sheth, N. U., Serrano, M. G., Glascock, A. L., Fettweis, J. M., Buck, G. A., & Jefferson, K. K. (2016). Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria. Microbiology, 162(Pt 3), 466-475.
Mayo Clinic. (2023). Bacterial vaginosis. Mayo Clinic.
McKinnon, K. M. (2018). Flow cytometry: An overview. Current Protocols in Immunology, 120, 5.1.1.
Sielatycka, K., Śliwa-Dominiak, J., Radaczyńska, M., Juzwa, W., Kaczmarczyk, M., Marlicz, W., Skonieczna-Żydecka, K., & Łoniewski, I. (2023). Dynamics of active fluorescent units (AFU) and water activity (aw) changes in probiotic products — pilot study. Foods, 12(21).
CDP. (2017). New report shows just 100 companies are source of over 70% of emissions. CDP.
Forest Stewardship Council. (n.d.). Certification. FSC.
Europlas. (n.d.). Is PET plastic biodegradable? Europlas.
National Center for Complementary and Integrative Health. (2019). Probiotics: Usefulness and safety. NCCIH.
Sorrenti, V., Randazzo, C. L., Caggia, C., Ballistreri, G., Romeo, F. V., Fabroni, S., Timpanaro, N., Raffaele, M., & Vanella, L. (2019). Beneficial effects of pomegranate peel extract and probiotics on pre-adipocyte differentiation. Frontiers in Microbiology, 10.
Kamali, M., Tavakoli, H., Khodadoost, M., Daghaghzadeh, H., Kamalinejad, M., Gachkar, L., Mansourian, M., & Adibi, P. (2015). Efficacy of the Punica granatum peels aqueous extract for symptom management in ulcerative colitis patients: A randomized, placebo-controlled, clinical trial. Complementary Therapies in Clinical Practice, 21(3), 141-146.
Rizzo, G., Pineda Chavez, S. E., Vandenkoornhuyse, E., Cárdenas Rincón, C. L., Cento, V., Garlatti, V., Wozny, M., Sammarco, G., Claudio, A. D., Meanti, L., Elangovan, S., Romano, A., Roda, G., Loy, L., Buono, A. D., Gabbiadini, R., Lovisa, S., Rusconi, R., Repici, A., et al. (2023). Pomegranate extract affects gut biofilm forming bacteria and promotes intestinal mucosal healing regulating the crosstalk between epithelial cells and intestinal fibroblasts. Nutrients, 15(7).
Mills, S., Yang, B., Smith, G. J., Stanton, C., & Ross, R. P. (2023). Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond. Gut Microbes, 15(1).
Giannetti, E., Maglione, M., Alessandrella, A., Strisciuglio, C., De Giovanni, D., Campanozzi, A., Miele, E., & Staiano, A. (2017). A mixture of 3 Bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: A multicenter, randomized, double-blind, placebo-controlled, crossover trial. Journal of Clinical Gastroenterology, 51(1), e5-e10.
Wu, BB., Yang, Y., Xu, X. et al. (2015). Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants. World Journal of Pediatrics, 12, 177-182.
Wong, C. B., Odamaki, T., & Xiao, J. (2019). Beneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: Modulation of gut microbiome as the principal action. Journal of Functional Foods, 54, 506-519.
Del Piano, M., Carmagnola, S., Anderloni, A., Andorno, S., Ballarè, M., Balzarini, M., Montino, F., Orsello, M., Pagliarulo, M., Sartori, M., Tari, R., Sforza, F., & Capurso, L. (2010). The use of probiotics in healthy volunteers with evacuation disorders and hard stools: A double-blind, randomized, placebo-controlled study. Journal of Clinical Gastroenterology, 44(Suppl. 1), S30-34.
Mogna, L., Del Piano, M., Deidda, F., Nicola, S., Soattini, L., Debiaggi, R., Sforza, F., Strozzi, G., & Mogna, G. (2012). Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. Journal of Clinical Gastroenterology, 46 (Suppl.), S29-32.
American Society for Microbiology. (2011). FAQ: E. coli: Good, bad & deadly. National Library of Medicine.
Del Piano, M., Anderloni, A., Balzarini, M., Ballarè, M., Carmagnola, S., Montino, F., Orsello, M., Pagliarulo, M., Tari, R., Soattini, L., Sforza, F., Mogna, L., & Mogna, G. (2012). The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI: A pilot study. Journal of Clinical Gastroenteroly, 46(Suppl.), S18-26.
Magistrelli, L., Amoruso, A., Mogna, L., Graziano, T., Cantello, R., Pane, M., & Comi, C. (2019). Probiotics may have beneficial effects in Parkinson's disease: In vitro evidence. Frontiers in Immunology, 10, 423550.
Chung, Y., Kang, S. B., Son, D., Lee, J. Y., Chung, M. J., & Lim, S. (2023). Characterization of the probiotic properties of Lacticaseibacillus rhamnosus LR6 isolated from the vaginas of healthy Korean women against vaginal pathogens. Frontiers in Microbiology, 14.
Ma, Z. F., Yusof, N., Hamid, N., & Lawenko, R. A. (2018). Bifidobacterium infantis M-63 improves mental health in victims with irritable bowel syndrome developed after a major flood disaster. Beneficial Microbes, 10(2), 1-10.
Cleveland Clinic. (2023). The gut-brain connection. Cleveland connection.
Staudacher, H. M., Black, C. J., Teasdale, S. B., Mikocka-Walus, A., & Keefer, L. (2023). Irritable bowel syndrome and mental health comorbidity — approach to multidisciplinary management. Nature Reviews. Gastroenterology & Hepatology, 1-15.
Segers, M. E., & Lebeer, S. (2014). Towards a better understanding of Lactobacillus rhamnosus GG–host interactions. Microbial Cell Factories, 13(Suppl. 1), S7.
Climent, E., Martinez-Blanch, J. F., Llobregat, L., Ruzafa-Costas, B., Carrión-Gutiérrez, M. Á., Ramírez-Boscá, A., Prieto-Merino, D., Genovés, S., Codoñer, F. M., Ramón, D., Chenoll, E., & Navarro-López, V. (2021). Changes in gut microbiota correlates with response to treatment with probiotics in patients with atopic dermatitis: A post hoc analysis of a clinical trial. Microorganisms, 9(4).
Balaguer, F., Enrique, M., Llopis, S., Barrena, M., Navarro, V., Álvarez, B., Chenoll, E., Ramón, D., Tortajada, M., & Martorell, P. (2022). Lipoteichoic acid from Bifidobacterium animalis subsp. lactis BPL1: A novel postbiotic that reduces fat deposition via IGF‐1 pathway. Microbial Biotechnology, 15(3), 805-816.
Pessemier, B. D., Grine, L., Debaere, M., Maes, A., Paetzold, B., & Callewaert, C. (2021). Gut–skin axis: Current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms, 9(2).
Martorell, P., Alvarez, B., Llopis, S., Navarro, V., Ortiz, P., Gonzalez, N., Balaguer, F., Rojas, A., Chenoll, E., Ramón, D., & Tortajada, M. (2021). Heat-treated Bifidobacterium longum CECT-7347: A whole-cell postbiotic with antioxidant, anti-inflammatory, and gut-barrier protection properties. Antioxidants (Basel), 10(4), 536.
Navarro-López, V., Ramírez-Boscá, A., Ramón-Vidal, D., et al. (2018). Effect of oral administration of a mixture of probiotic strains on scorad index and use of topical steroids in young patients with moderate atopic dermatitis: A randomized clinical trial. JAMA Dermatology, 154(1), 37-43.
Codoñer, F. M., Climent, E., Guerrero, M., Manuel, J., Genovés, S., Ramón, D., & Chenoll, E. (2018). Gut microbial composition in patients with psoriasis. Scientific Reports, 8(1), 1-7.
Mogna, L., & Mogna, G. (2012). Innovative probiotics and systemic bioactive metabolites: Anti-ageing potential. Nutrafoods, 11, 151-164.
Mount Sinai. (n.d.). Vitamin B12 (Cobalamin). Mount Sinai.
Bron, P. A., Catalayud, M., Marzorati, M., Pane, M., Kartal, E., Dhir, R., & Reid, G. (2021). Delivery of metabolically neuroactive probiotics to the human gut. International Journal of Molecular Sciences, 22(17), 9122.
Pan, M., Hidalgo-Cantabrana, C., & Barrangou, R. (2020). Host and body site-specific adaptation of Lactobacillus crispatus genomes. NAR Genomics and Bioinformatics, 2(1).
Tierney, B. T., Al-Ghalith, G. A., Verstrepen, L., Ghyselinck, J., Calatayud, M., Marzorati, M., Gadir, A. A., Daisley, B., Reid, G., Bron, P. A., Gevers, D., Dhir, R., & Simmons, S. L. (2023). Capacity of a microbial synbiotic to rescue the in vitro metabolic activity of the gut microbiome following perturbation with alcohol or antibiotics. Applied and Environmental Microbiology, 89(3).
Kolisa, S., Hernandez, O., O’Hara, S. P., & Rastall, R. A. (2020). Mechanisms of cholesterol reduction by Lactobacillus plantarum LPLDL®. Optbiotix Health.
Jungersen, M., Wind, A., Johansen, E., Christensen, J. E., Stuer-Lauridsen, B., & Eskesen, D. (2014). The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12®. Microorganisms, 2(2), 92-110.
Capurso, L. (2019). Thirty years of Lactobacillus rhamnosus GG: A review. Journal of Clinical Gastroenterology, 53(Suppl. 1), S1-S41.
MedlinePlus. (2023). Bacillus coagulans. MedlinePlus.
Li, G., Tong, Y., Xiao, Y., Huang, S., Zhao, T., & Xia, X. (2023). Probiotic Bacillus subtilis contributes to the modulation of gut microbiota and blood metabolic profile of hosts. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 272, 109712.
Dang, H. T., Tran, D. M., Phung, T. T., Bui, A. T., Vu, Y. H., Luong, M. T., Nguyen, H. M., Trinh, H. T., Nguyen, T. T., Nguyen, A. H., & Van Nguyen, A. T. (2024). Promising clinical and immunological efficacy of Bacillus clausii spore probiotics for supportive treatment of persistent diarrhea in children. Scientific Reports, 14(1), 1-16.
Han, S., Lu, Y., Xie, J., Fei, Y., Zheng, G., Wang, Z., Liu, J., Lv, L., Ling, Z., Berglund, B., Yao, M., & Li, L. (2021). Probiotic gastrointestinal transit and colonization after oral administration: a long journey. Frontiers in Cellular and Infection Microbiology, 11.
Ranadheera, S., & Said, A. (2019). Making the most of probiotics. Pursuit.
Bezkorovainy, A. (2001). Probiotics: Determinants of survival and growth in the gut. The American Journal of Clinical Nutrition, 73(2), 399s-405s.
Van de Wiele, T., Van den Abbeele, P., Ossieur, W., et al. (2015). The Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). In: The Impact of Food Bioactives on Health: In vitro and ex vivo models [Internet], chapter 27.
Vivek, K., Mishra, S., Pradhan, R. C., Nagarajan, M., Kumar, P. K., Singh, S. S., Manvi, D., & Gowda, N. N. (2023). A comprehensive review on microencapsulation of probiotics: Technology, carriers and current trends. Applied Food Research, 3(1), 100248.
Ringel, Y., Ringel-Kulka, T., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., & Palsson, O. S. (2011). Clinical trial: Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders — a double-blind study. Journal of Clinical Gastroenterology, 45(6), 518.
Rasinkangas, P., Forssten, S. D., Marttinen, M., Ibarra, A., Bothe, G., Junnila, J., Uebelhack, R., Donazzolo, Y., & Ouwehand, A. C. (2022). Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials. The American Journal of Clinical Nutrition, 116(6), 1580-1594.
Maneerat, S., Lehtinen, M. J., Childs, C. E., Forssten, S. D., Alhoniemi, E., Tiphaine, M., Yaqoob, P., Ouwehand, A. C., & Rastall, R. A. (2013). Consumption of Bifidobacterium lactis Bi-07 by healthy elderly adults enhances phagocytic activity of monocytes and granulocytes. Journal of Nutritional Science, 2.
Cionci, N. B., Baffoni, L., Gaggìa, F., & Gioia, D. D. (2018). Therapeutic microbiology: The role of Bifidobacterium breve as food supplement for the prevention/treatment of paediatric diseases. Nutrients, 10(11).
Drago, L., Cioffi, L., Giuliano, M., Pane, M., Amoruso, A., Schiavetti, I., Reid, G., Ciprandi, G., & Group, P. S. (2022). The Probiotics in Pediatric Asthma Management (PROPAM) study in the primary care setting: A randomized, controlled, double-blind trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706). Journal of Immunology Research, 2022(1), 3837418.
Drago, L., Vecchi, E. D., Gabrieli, A., Grandi, R. D., & Toscano, M. (2015). Immunomodulatory effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, alone and in combination, on peripheral blood mononuclear cells of allergic asthmatics. Allergy, Asthma & Immunology Research, 7(4), 409-413.
Dou, Y., Yu, X., Luo, Y., Chen, B., Ma, D., & Zhu, J. (2022). Effect of fructooligosaccharides supplementation on the gut microbiota in human: A systematic review and meta-analysis. Nutrients, 14(16).
Watson, A. W., Houghton, D., Avery, P. J., Stewart, C., Vaughan, E. E., Meyer, P. D., Kuil, B., Weijs, J. M., & Brandt, K. (2019). Changes in stool frequency following chicory inulin consumption, and effects on stool consistency, quality of life and composition of gut microbiota. Food Hydrocolloids, 96, 688-698.
Dairy Foods. (2018). FDA upholds dietary fiber status for chicory root. Dairy Foods.
Rhys-Jones, D., & Collins, L. (2021). Update: Label readings and FODMAPS. Monash University.
Veloso, H. G. (n.d.). FODMAP diet: What you need to know. Johns Hopkins Medicine.
Colom, J., Freitas, D., Simon, A., Khokhlova, E., Mazhar, S., Buckley, M., Phipps, C., Deaton, J., Brodkorb, A., & Rea, K. (2023). Acute physiological effects following Bacillus subtilis DE111 oral ingestion — a randomised, double blinded, placebo-controlled study. Beneficial Microbes, 14(1), 31-44.
Majeed, M., Nagabhushanam, K., Arumugam, S., Chadalavada, N., Seepana, J., Annamalai, T., Murali, A., Prakasan, P., & Mundkur, L. (2024). Probiotic Weizmannia coagulans MTCC 5856 as adjunct therapy in children's acute diarrhea — a randomized, double-blind, placebo-controlled study. Frontiers in Pediatrics, 11, 1338126.
He, T., Lykov, N., Luo, X., Wang, H., Du, Z., Chen, Z., Chen, S., Zhu, L., Zhao, Y., & Tzeng, C. (2023). Protective effects of Lactobacillus gasseri against high-cholesterol diet-induced fatty liver and regulation of host gene expression profiles. International Journal of Molecular Sciences, 24(3).
Garcia-Gonzalez, N., Battista, N., Prete, R., & Corsetti, A. (2021). Health-promoting role of Lactiplantibacillus plantarum isolated from fermented foods. Microorganisms, 9(2).
Paraskevakos, G. (2021). Bifidobacterium lactis. International Probiotics Association.
Hill, D., Sugrue, I., Tobin, C., Hill, C., Stanton, C., & Ross, R. P. (2018). The lactobacillus casei group: History and health related applications. Frontiers in Microbiology, 9, 405810.
Gao, H., Li, X., Chen, X., Hai, D., Wei, C., Zhang, L., & Li, P. (2022). The functional roles of Lactobacillus acidophilus in different physiological and pathological processes. Journal of Microbiology and Biotechnology, 32(10), 1226-1233.
Hu, G., Wang, Y., Cao, Y., Wu, W., & Zhang, L. (2020). Prebiotic maltose gel can promote the vaginal microbiota from BV-related bacteria dominant to Lactobacillus in rhesus macaque. Frontiers in Microbiology, 11.
Wawrzyniak, N., Gramza-Michałowska, A., Kołodziejski, P. & Suliburska, J. (2022). Effect of calcium lactate in standard diet on selected markers of oxidative stress and inflammation in ovariectomized rats. Open Chemistry, 20(1), 1357-1364.
Ravel, J., Greenwood Jaswa, E., Gottfried, S., Greene, M., Kellogg-Spadt, S., Gevers, D., & Harper, D. (2024). A novel multi-strain vaginal synbiotic is effective in optimizing the vaginal microbiome: Results from a randomized, placebo-controlled clinical trial. medRxiv (Preprint).
Patel, S. (2023). The pros and cons of preprints. MDPI Blog.
Drozdz, J. A., & Ladomery, M. R. (2024). The peer review process: Past, present, and future. British Journal of Biomedical Science, 81.
Chen, R., Li, R., Qing, W. et al. (2022). Probiotics are a good choice for the treatment of bacterial vaginosis: A meta-analysis of randomized controlled trial. Reprodtive Health, 19, 137.
Ouwehand, A., & Lehtoranta, L. (2021). Probiotics for vaginal health; oral consumption vs. local application. Nutracos, 20(3).
Mogha, K. V., & Prajapati, J. B. (2016). Probiotics for treating bacterial vaginosis. Reviews in Medical Microbiology, 27(3), 87-94.
Wei, L., Singh, R., Ro, S., & Ghoshal, U. C. (2021). Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open: An Open Access Journal of Gastroenterology and Hepatology, 5(9), 976-987.
Van de Wijgert, J. H., & Jespers, V. (2017). The global health impact of vaginal dysbiosis. Research in Microbiology, 168(9-10), 859-864.
Martinez, J. E., Kahana, D. D., Ghuman, S., Wilson, H. P., Wilson, J., Kim, S. C., Lagishetty, V., Jacobs, J. P., P., A., & Friedman, T. C. (2021). Unhealthy lifestyle and gut dysbiosis: A better understanding of the effects of poor diet and nicotine on the intestinal microbiome. Frontiers in Endocrinology, 12, 667066.
Lehtoranta, L., Laitila, A., & Maukonen, J. (2022). Healthy vaginal microbiota and influence of probiotics across the female life span. Frontiers in Microbiology, 13, 819958.
Harvard Health Publishing. (2022). Should you take probiotics? Harvard Health Publishing.
California Office of Environmental Health Hazard Assessment. (2023). Proposition 65 No Significant Risk Levels (NSRLs) and Maximum Allowable Dose Levels (MADLs). OEHHA.
Dore, M. P., Bibbò, S., Fresi, G., Bassotti, G., & Pes, G. M. (2019). Side effects associated with probiotic use in adult patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled trials. Nutrients, 11(12).
Grubb, D. S., Wrigley, S. D., Freedman, K. E., Wei, Y., Vazquez, A. R., Trotter, R. E., Wallace, T. C., Johnson, S. A., & Weir, T. L. (2020). PHAGE-2 study: Supplemental bacteriophages extend Bifidobacterium animalis subsp. lactis BL04 benefits on gut health and microbiota in healthy adults. Nutrients, 12(8), 2474.
Banasiewicz, T., Domagalska, D., Borycka-Kiciak, K., & Rydzewska, G. (2020). Determination of butyric acid dosage based on clinical and experimental studies — a literature review. Przegla̜d Gastroenterologiczny, 15(2), 119-125.
Golen, T., & Ricciotti, H. (2021). What are postbiotics? Harvard Health Publishing.
Lin, H., Chou, M., Chien, W., Chang, S., & Lin, I. (2016). Prebiotic effects of xylooligosaccharides on the improvement of microbiota balance in human subjects. Gastroenterology Research and Practice, 2016.
Wang, H., Chen, G., Li, X., Zheng, F., & Zeng, X. (2020). Yeast β-glucan, a potential prebiotic, showed a similar probiotic activity to inulin. Food & Function, 11(12), 10386-10396.
Qin, Y. Q., Wang, L. Y., Yang, X. Y., Xu, Y. J., Fan, G., Fan, Y. G., Ren, J. N., An, Q., & Li, X. (2023). Inulin: Properties and health benefits. Food & Function, 14(7), 2948-2968.
Petrova, M. I., Reid, G., & Ter Haar, J. A. (2021). Lacticaseibacillus rhamnosus GR-1, a.k.a. Lactobacillus rhamnosus GR-1: Past and future perspectives. Trends in Microbiology, 29(8), 747-761.
Rafael, C. R., Martinez, R. C. R., Martinez, S. A., Franceschini, S. A., Franceschini, M. C., et al. (2009). Improved cure of bacterial vaginosis with single dose of tinidazole (2g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: A randomized, double-blind, placebo-controlled trial. Canadian Journal of Microbiology, 55(2), 133-138.
Zhang, Y., Lyu, J., Ge, L., Huang, L., Peng, Z., Liang, Y., Zhang, X., & Fan, S. (2021). Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an adjunctive treatment for bacterial vaginosis do not increase the cure rate in a chinese cohort: A prospective, parallel‐group, randomized, controlled study. Frontiers in Cellular and Infection Microbiology, 11, 669901.
Vivekanandan, V., Khan, Z. H., Venugopal, G., Musunuru, B., Mishra, P., Srivastava, S., Ramadass, B., & Subhadra, B. (2024). VagiBIOM Lactobacillus suppository improves vaginal health index in perimenopausal women with bacterial vaginosis: A randomized control trial. Scientific Reports, 14(1), 1-13.
Yoha, K. S., Nida, S., Dutta, S., Moses, J. A., & Anandharamakrishnan, C. (2022). Targeted delivery of probiotics: Perspectives on research and commercialization. Probiotics and Antimicrobial Proteins, 14(1), 15-48.
Wilcox, H., Carr, C., Seney, S., Reid, G., & Burton, J. P. (2021). Expired probiotics: What is really in your cabinet? FEMS Microbes, 1(1).
So, D. (2018). More than FODMAPs: fermentable fibres & IBS. Monash University.